Search research articles
Contact Us
Filters
Showing results (41-50 of 133) with videos related to
Page
of 14
Sort By:
Plos One
|
August 11, 2017
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatment
Lukasz Kuryk, Lotta Vassilev, Tuuli Ranki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors
Vincenzo Cerullo, Michael P Seiler, Viraj Mane, et al.
Chemical Communications (Cambridge, England)
|
August 10, 2012
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system
Stefano D'Errico, Giorgia Oliviero, Jussara Amato, et al.
Plos One
|
October 8, 2010
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5
Marko T Ahonen, Iulia Diaconu, Sari Pesonen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2026
Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice
Maria Vitale, Filippo Scialò, Ludovica Coluccino, et al.
International Journal of Molecular Sciences
|
September 2, 2020
Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma
Beatrice Polini, Sara Carpi, Stefano Doccini, et al.
Leukemia
|
August 23, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer
Brittany L Ford, Emmi Jokinen, Jani Huuhtanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance
Vincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Human Gene Therapy
|
January 6, 2015
Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus
Mari Hirvinen, Maria Rajecki, Mika Kapanen, et al.
Plos One
|
October 24, 2019
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
Leena Ylösmäki, Beatrice Polini, Sara Carpi, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 133) with videos related to
Sort By:
Page
of 14
Plos One
|
August 11, 2017
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatment
Lukasz Kuryk, Lotta Vassilev, Tuuli Ranki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 20, 2007
Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors
Vincenzo Cerullo, Michael P Seiler, Viraj Mane, et al.
Chemical Communications (Cambridge, England)
|
August 10, 2012
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system
Stefano D'Errico, Giorgia Oliviero, Jussara Amato, et al.
Plos One
|
October 8, 2010
Calcium gluconate in phosphate buffered saline increases gene delivery with adenovirus type 5
Marko T Ahonen, Iulia Diaconu, Sari Pesonen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 15, 2026
Helper-dependent adenoviral vector-mediated expression of an LDL receptor/transferrin chimeric protein in muscle safely reduces atherosclerosis in LDLR-deficient mice
Maria Vitale, Filippo Scialò, Ludovica Coluccino, et al.
International Journal of Molecular Sciences
|
September 2, 2020
Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma
Beatrice Polini, Sara Carpi, Stefano Doccini, et al.
Leukemia
|
August 23, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancer
Brittany L Ford, Emmi Jokinen, Jani Huuhtanen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance
Vincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Human Gene Therapy
|
January 6, 2015
Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus
Mari Hirvinen, Maria Rajecki, Mika Kapanen, et al.
Plos One
|
October 24, 2019
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy
Leena Ylösmäki, Beatrice Polini, Sara Carpi, et al.
Page
of 14